Radiopharmaceuticals Market By Type, Procedural Volumes and Application- Global Industry Analysis and Forecast to 2023

Published On : January 2018 Pages : 100 Category: Pharmaceuticals Report Code : HC01517

Industry Outlook and Trend Analysis

The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period. The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market.

Type Outlook and Trend Analysis

On the basis of type, the market is fragmented into therapeutic and diagnostic. The diagnostic portion represented the biggest share of the nuclear medicine market. The diagnostic portion is additionally fragmented into PET and SPECT. In 2016, the SPECT section represented the biggest share of the radiopharmaceuticals diagnostic market. The therapeutic fragment is additionally divided into brachytherapy, alpha emitters, and beta emitters. In 2016, the beta producers section represented the biggest share of the atomic prescription/radiopharmaceuticals therapeutic market.

Application Outlook and Trend Analysis

Based on application, the radiopharmaceuticals market is fragmented into PET, SPECT and therapeutic applications. In 2016, the cardiology application section represented the biggest share of the atomic medication SPECT applications market. The atomic radiopharmaceuticals PET applications market was ruled by the oncology section, while the radiopharmaceuticals therapeutic applications market was ruled by the thyroid application fragment.

Regional Outlook and Trend Analysis

Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World.  North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others.

Competitive Insights

The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.

By Type

  • Diagnostic Nuclear Medicine/Radiopharmaceuticals
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Nuclear Medicine/Radiopharmaceuticals
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy

By Procedural Volumes

  • Diagnostic Procedures
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Procedures
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy

By Application

  • Diagnostic Applications
  • SPECT
  • PET
  • Therapeutic Applications
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Other

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

Market Classification

  • Radiopharmaceuticals Market, By Type, Estimates and Forecast, 2014-2023($Billion)
  • Diagnostic Nuclear Medicine/Radiopharmaceuticals
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Nuclear Medicine/Radiopharmaceuticals
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy
  • Radiopharmaceuticals Market, By Procedural Volumes, Estimates and Forecast, 2014-2023($Billion)
  • Diagnostic Procedures
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Procedures
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy
  • Radiopharmaceuticals Market, By Application, Estimates and Forecast, 2014-2023($Billion)
  • Diagnostic Applications
  • SPECT
  • PET
  • Therapeutic Applications
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Other Therapeutic Applications
  • Radiopharmaceuticals Market, By Region, Estimates and Forecast, 2014-2023($Billion)
    • North America
  • North America Radiopharmaceuticals Market, By Country
  • North America Radiopharmaceuticals Market, By Type
  • North America Radiopharmaceuticals Market, By Procedural Volumes
  • North America Radiopharmaceuticals Market, By Application
    • U.S. Radiopharmaceuticals Market, By Type
    • U.S. Radiopharmaceuticals Market, By Procedural Volumes
    • U.S. Radiopharmaceuticals Market, By Application
    • Canada Radiopharmaceuticals Market, By Type
    • Canada Radiopharmaceuticals Market, By Procedural Volumes
    • Canada Radiopharmaceuticals Market, By Application
    • Mexico Radiopharmaceuticals Market, By Type
    • Mexico Radiopharmaceuticals Market, By Procedural Volumes
    • Mexico Radiopharmaceuticals Market, By Application

 

    • Europe
      • Europe Radiopharmaceuticals Market, By Country
      • Europe Radiopharmaceuticals Market, By Type
      • Europe Radiopharmaceuticals Market, By Procedural Volumes
      • Europe Radiopharmaceuticals Market, By Application
        • Germany Radiopharmaceuticals Market, By Type
        • Germany Radiopharmaceuticals Market, By Procedural Volumes
        • Germany Radiopharmaceuticals Market, By Application
        • France Radiopharmaceuticals Market, By Type
        • France Radiopharmaceuticals Market, By Procedural Volumes
        • France Radiopharmaceuticals Market, By Application
        • UK Radiopharmaceuticals Market, By Type
        • UK Radiopharmaceuticals Market, By Procedural Volumes
        • UK Radiopharmaceuticals Market, By Application
        • Italy Radiopharmaceuticals Market, By Type
        • Italy Radiopharmaceuticals Market, By Procedural Volumes
        • Italy Radiopharmaceuticals Market, By Application
        • Spain Radiopharmaceuticals Market, By Type
        • Spain Radiopharmaceuticals Market, By Procedural Volumes
        • Spain Radiopharmaceuticals Market, By Application
        • Rest of Europe Radiopharmaceuticals Market, By Type
        • Rest of Europe Radiopharmaceuticals Market, By Procedural Volumes
        • Rest of Europe Radiopharmaceuticals Market, By Application
    • Asia-Pacific
      • Asia-Pacific Radiopharmaceuticals Market, By Country
      • Asia-Pacific Radiopharmaceuticals Market, By Type
      • Asia-Pacific Radiopharmaceuticals Market, By Procedural Volumes
      • Asia-Pacific Radiopharmaceuticals Market, By Application
        • Japan Radiopharmaceuticals Market, By Type
        • Japan Radiopharmaceuticals Market, By Procedural Volumes
        • Japan Radiopharmaceuticals Market, By Application
        • Australia Radiopharmaceuticals Market, By Type
        • Australia Radiopharmaceuticals Market, By Procedural Volumes
        • Australia Radiopharmaceuticals Market, By Application
        • India Radiopharmaceuticals Market, By Type
        • India Radiopharmaceuticals Market, By Procedural Volumes
        • India Radiopharmaceuticals Market, By Application
        • South Korea Radiopharmaceuticals Market, By Type
        • South Korea Radiopharmaceuticals Market, By Procedural Volumes
        • South Korea Radiopharmaceuticals Market, By Application
        • Rest of Asia-Pacific Radiopharmaceuticals Market, By Type
        • Rest of Asia-Pacific Radiopharmaceuticals Market, By Procedural Volumes
        • Rest of Asia-Pacific Radiopharmaceuticals Market, By Application
    • Rest of the World
      • Rest of the World Radiopharmaceuticals Market, By Country
      • Rest of the World Radiopharmaceuticals Market, By Type
      • Rest of the World Radiopharmaceuticals Market, By Procedural Volumes
      • Rest of the World Radiopharmaceuticals Market, By Application
        • Brazil Radiopharmaceuticals Market, By Type
        • Brazil Radiopharmaceuticals Market, By Procedural Volumes
        • Brazil Radiopharmaceuticals Market, By Application
        • South Africa Radiopharmaceuticals Market, By Type
        • South Africa Radiopharmaceuticals Market, By Procedural Volumes
        • South Africa Radiopharmaceuticals Market, By Application
        • Saudi Arabia Radiopharmaceuticals Market, By Type
        • Saudi Arabia Radiopharmaceuticals Market, By Procedural Volumes
        • Saudi Arabia Radiopharmaceuticals Market, By Application
        • Turkey Radiopharmaceuticals Market, By Type
        • Turkey Radiopharmaceuticals Market, By Procedural Volumes
        • Turkey Radiopharmaceuticals Market, By Application
        • United Arab Emirates Radiopharmaceuticals Market, By Type
        • United Arab Emirates Radiopharmaceuticals Market, By Procedural Volumes
        • United Arab Emirates Radiopharmaceuticals Market, By Application
        • Others Radiopharmaceuticals Market, By Type
        • Others Radiopharmaceuticals Market, By Procedural Volumes
        • Others Radiopharmaceuticals Market, By Application

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Alpha Radioimmunotherapy (Rit)-Based Targeted Cancer Treatment

3.2.1.2.    Increasing Incidence and Prevalence of Cancer and Cardiac Ailments

3.2.2.  Restraints

3.2.2.1.    High Cost of Nuclear Medicine Equipment

3.2.2.2.    Shorter Half-Life of Radiopharmaceuticals

3.2.3.  Opportunities

3.2.3.1.    Emerging Countries to Offer Lucrative Growth Opportunities

3.2.3.2.    Use of Radiopharmaceuticals in Neurological Applications

4.       Radiopharmaceuticals Market, By Type

4.1.       Introduction

4.2.       Global Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2017)

4.2.1.  Global Radiopharmaceuticals Sales and Sales Share by Type (2014-2017)

4.2.2.  Global Radiopharmaceuticals Revenue and Revenue Share by Type (2014-2017)

4.3.       Radiopharmaceuticals Market   Assessment and Forecast, By Type, 2014-2023

4.4.       Diagnostic Radiopharmaceuticals

4.4.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

4.4.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.4.3.  SPECT Radiopharmaceuticals

4.4.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.4.4.  PET Radiopharmaceuticals

4.4.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.5.       Therapeutic Radiopharmaceuticals

4.5.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

4.5.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.5.3.  Beta Emitters

4.5.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.5.4.  Alpha Emitters

4.5.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.5.5.  Brachytherapy

4.5.5.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.       Radiopharmaceuticals Market, By Procedural Volumes

5.1.       Introduction

5.2.       Global Radiopharmaceuticals Sales, Revenue and Market Share by Procedural Volumes (2014-2017)

5.2.1.  Global Radiopharmaceuticals Sales and Sales Share by Procedural Volumes (2014-2017)

5.2.2.  Global Radiopharmaceuticals Revenue and Revenue Share by Procedural Volumes (2014-2017)

5.3.       Radiopharmaceuticals Market   Assessment and Forecast, By Procedural Volumes, 2014-2023

5.4.       Diagnostic Procedures

5.4.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

5.4.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.4.3.  SPECT Radiopharmaceuticals

5.4.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.4.4.  PET Radiopharmaceuticals

5.4.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.5.       Therapeutic Procedures

5.5.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

5.5.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.5.3.  Beta Emitters

5.5.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.5.4.  Alpha Emitters

5.5.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

5.5.5.  Brachytherapy

5.5.5.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.       Radiopharmaceuticals Market, By Application

6.1.       Introduction

6.2.       Global Radiopharmaceuticals Sales, Revenue and Market Share by Application (2014-2017)

6.2.1.  Global Radiopharmaceuticals Sales and Sales Share by Application (2014-2017)

6.2.2.  Global Radiopharmaceuticals Revenue and Revenue Share by Application (2014-2017)

6.3.       Radiopharmaceuticals Market   Assessment and Forecast, By Application, 2014-2023($Billion)

6.4.       Diagnostic Applications

6.4.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

6.4.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.4.3.  SPECT

6.4.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.4.4.  PET

6.4.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.       Therapeutic Applications

6.5.1.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.3.  Thyroid

6.5.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.4.  Bone Metastasis

6.5.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.5.  Lymphoma

6.5.5.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.6.  Endocrine Tumors

6.5.6.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

6.5.7.  Other Therapeutic Applications

6.5.7.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

7.       Radiopharmaceuticals Market, By Region

7.1.       Introduction

7.2.       Radiopharmaceuticals Market   Assessment and Forecast, By Region, 2014-2023($Billion)

7.3.       Global Radiopharmaceuticals Sales, Revenue and Market Share by Regions

7.3.1.  Global Radiopharmaceuticals Sales by Regions (2014-2017)

7.3.2.  Global Radiopharmaceuticals Revenue by Regions (2014-2017)

7.4.       North America

7.4.1.  North America Radiopharmaceuticals Sales and Growth Rate (2014-2017)

7.4.2.  Market Assessment and Forecast, By Country, 2014-2023($Billion)

7.4.3.  Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.4.4.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.4.5.  Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.4.6.  U.S.

7.4.6.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.4.6.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.4.6.1.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.4.6.2.    Canada

7.4.6.2.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.4.6.2.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.4.6.2.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.4.6.3.    Mexico

7.4.6.3.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.4.6.3.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.4.6.3.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.       Europe

7.5.1.  Europe Radiopharmaceuticals Sales and Growth Rate (2014-2017)

7.5.2.  Market Assessment and Forecast, By Country, 2014-2023($Billion)

7.5.3.  Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.4.  Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.5.  Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.6.  Germany

7.5.6.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.6.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.6.1.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.7.  France

7.5.7.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.7.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.7.1.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.8.  UK

7.5.8.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.8.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.8.1.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.9.  Italy

7.5.9.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.9.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.9.1.3.    Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.10.      Spain

7.5.10.1.1. Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.10.1.2. Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.10.1.3. Market Assessment and Forecast, By Application, 2014-2023($Billion)

7.5.10.2. Rest of Europe

7.5.10.2.1. Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

7.5.10.2.2. Market Assessment and Forecast, By Type, 2014-2023($Billion)

7.5.10.2.3. Market Assessment and Forecast, By Application, 2014-2023($Billion)

8.       Asia-Pacific

8.1.1.  Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2014-2017)

8.1.2.  Market Assessment and Forecast, By Country, 2014-2023($Billion)

8.1.3.  Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.4.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.5.  Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.5.1.    Japan

8.1.5.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.5.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.5.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.6.  China

8.1.6.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.6.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.6.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.7.  Australia

8.1.7.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.7.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.7.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.8.  India

8.1.8.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.8.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.8.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.9.  South Korea

8.1.9.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.9.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.9.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

8.1.10.      Rest of Asia-Pacific

8.1.10.1.1. Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

8.1.10.1.2. Market Assessment and Forecast, By Type, 2014-2023($Billion)

8.1.10.1.3. Market Assessment and Forecast, By Application,2014-2023($Billion)

9.       Rest of the World

9.1.1.  Rest of the World Radiopharmaceuticals Sales and Growth Rate (2014-2017)

9.1.2.  Market Assessment and Forecast, By Country, 2014-2023($Billion)

9.1.3.  Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.4.  Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.5.  Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.6.  Brazil

9.1.6.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.6.1.2.    Market Assessment and Forecast, By Type , 2014-2023($Billion)

9.1.6.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.7.  Turkey

9.1.7.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.7.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

9.1.7.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.8.  Saudi Arabia

9.1.8.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.8.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

9.1.8.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.9.  South Africa

9.1.9.1.1.    Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.9.1.2.    Market Assessment and Forecast, By Type, 2014-2023($Billion)

9.1.9.1.3.    Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.10.      United Arab Emirates

9.1.10.1.1. Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.10.1.2. Market Assessment and Forecast, By Type, 2014-2023($Billion)

9.1.10.1.3. Market Assessment and Forecast, By Application,2014-2023($Billion)

9.1.11.      Others

9.1.11.1.1. Market Assessment and Forecast, By Procedural Volumes, 2014-2023($Billion)

9.1.11.1.2. Market Assessment and Forecast, By Type, 2014-2023($Billion)

9.1.11.1.3. Market Assessment and Forecast, By Application,2014-2023($Billion)

10.   Company Profiles

10.1.      Cardinal Health, Inc.

10.1.1.      Business Overview

10.1.2.      Product Portfolio

10.1.3.      Strategic Developments

10.1.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.2.    Mallinckrodt PLC 

10.2.1.      Business Overview

10.2.2.      Product Portfolio

10.2.3.      Strategic Developments

10.2.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.3.    GE Healthcare

10.3.1.      Business Overview

10.3.2.      Product Portfolio

10.3.3.      Strategic Developments

10.3.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.4.    Lantheus Medical Imaging, Inc.

10.4.1.      Business Overview

10.4.2.      Product Portfolio

10.4.3.      Strategic Developments

10.4.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.5.    Bayer AG

10.5.1.      Business Overview

10.5.2.      Product Portfolio

10.5.3.      Strategic Developments

10.5.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.6.    Bracco Imaging S.P.A

10.6.1.      Business Overview

10.6.2.      Product Portfolio

10.6.3.      Strategic Developments

10.6.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.7.     Eczacibasi-Monrol Nuclear Products

10.7.1.      Business Overview

10.7.2.      Product Portfolio

10.7.3.      Strategic Developments

10.7.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.8.    Nordion, Inc.

10.8.1.      Business Overview

10.8.2.      Product Portfolio

10.8.3.      Strategic Developments

10.8.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.9.    Advanced Accelerator Applications S.A.

10.9.1.      Business Overview

10.9.2.      Product Portfolio

10.9.3.      Strategic Developments

10.9.4.      Radiopharmaceuticals Sales, Revenue and Market Share

10.10.Iba Molecular

10.10.1.  Business Overview

10.10.2.  Product Portfolio

10.10.3.  Strategic Developments

10.10.4.  Radiopharmaceuticals Sales, Revenue and Market Share

11.   Global Radiopharmaceuticals Market Competition, by Manufacturer

11.1.    Global Radiopharmaceuticals Sales and Market Share by Manufacturer (2016-2017)

11.2.    Global Radiopharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)

11.3.    Top 5 Radiopharmaceuticals Manufacturer Market Share

11.4.    Market Competition Trend


List of Tables

Table: Global Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Global Radiopharmaceuticals Sales and Sales Share by Type (2014-2017)

Table: Global Radiopharmaceuticals Revenue and Revenue Share by Type (2014-2017)

Table: Diagnostic Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Diagnostic Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: SPECT Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: PET Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: Therapeutic Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Therapeutic Nuclear Medicine/Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: Beta Emitters Market, By Region, 2014-2023($Million)

Table: Alpha Emitters Market, By Region, 2014-2023($Million)

Table: Brachytherapy Market, By Region, 2014-2023($Million)

Table: Global Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Global Radiopharmaceuticals Sales and Sales Share by Procedural Volumes (2014-2017)

Table: Global Radiopharmaceuticals Revenue and Revenue Share by Procedural Volumes (2014-2017)

Table: Diagnostic Procedures Market, By Type, 2014-2023($Million)

Table: Diagnostic Procedures Market, By Region, 2014-2023($Million)

Table: SPECT Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: PET Radiopharmaceuticals Market, By Region, 2014-2023($Million)

Table: Therapeutic Procedures Market, By Type, 2014-2023($Million)

Table: Therapeutic Procedures Market, By Region, 2014-2023($Million)

Table: Beta Emitters Market, By Region, 2014-2023($Million)

Table: Alpha Emitters Market, By Region, 2014-2023($Million)

Table: Brachytherapy Market, By Region, 2014-2023($Million)

Table: Global Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Global Radiopharmaceuticals Sales and Sales Share by Application (2014-2017)

Table: Global Radiopharmaceuticals Revenue and Revenue Share by Application (2014-2017)

Table: Diagnostic Applications Market, By Type, 2014-2023($Million)

Table: Diagnostic Applications Market, By Region, 2014-2023($Million)

Table: SPECT Market, By Region, 2014-2023($Million)

Table: PET Market, By Region, 2014-2023($Million)

Table: Therapeutic Applications Market, By Region, 2014-2023($Million)

Table: Therapeutic Applications Market, By Region, 2014-2023($Million)

Table: Thyroid Market, By Region, 2014-2023($Million)

Table: Bone Metastasis Market, By Region, 2014-2023($Million)

Table: Lymphoma Market, By Region, 2014-2023($Million)

Table: Endocrine Tumors Market, By Region, 2014-2023($Million)

Table: Others Therapeutic Applications Market, By Region, 2014-2023($Million)

Table: Global Radiopharmaceuticals Sales, Revenue and Market Share by Regions

Table: North America Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Table: North America Radiopharmaceuticals Market, By Country, 2014-2023($Million)

Table: North America Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: North America Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: North America Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: U.S. Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: U.S. Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: U.S. Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Canada Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Canada Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Canada Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Mexico Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Mexico Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Mexico Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Europe Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Table: Europe Radiopharmaceuticals Market, By Country, 2014-2023($Million)

Table: Europe Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Europe Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Europe Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Germany Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Germany Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Germany Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: France Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: France Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: France Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: UK Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: UK Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: UK Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Italy Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Italy Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Italy Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Spain Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Spain Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Spain Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Rest of Europe Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Rest of Europe Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Rest of Europe Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Table: Asia-Pacific Radiopharmaceuticals Market, By Country, 2014-2023($Million)

Table: Asia-Pacific Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Asia-Pacific Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Asia-Pacific Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Japan Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Japan Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Japan Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: China Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: China Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: China Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Australia Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Australia Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Australia Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: India Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: India Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: India Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: South Korea Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: South Korea Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: South Korea Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Rest of Asia-Pacific Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Rest of Asia-Pacific Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Rest of Asia-Pacific Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Rest of the World Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Table: Rest of the World Radiopharmaceuticals Market, By Country, 2014-2023($Million)

Table: Rest of the World Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: rest of the World Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Rest of the World Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Brazil Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Brazil Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Brazil Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Turkey Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Turkey Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Turkey Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Saudi Arabia Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Saudi Arabia Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Saudi Arabia Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: South Africa Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: South Africa Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: South Africa Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: United Arab Emirates Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: United Arab Emirates Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: United Arab Emirates Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Others Radiopharmaceuticals Market, By Procedural Volumes, 2014-2023($Million)

Table: Others Radiopharmaceuticals Market, By Type, 2014-2023($Million)

Table: Others Radiopharmaceuticals Market, By Application, 2014-2023($Million)

Table: Cardinal Health, Inc.: Key Strategic Developments, 2015-2017

Table: Mallinckrodt PLC: Key Strategic Developments, 2015-2017

Table: GE Healthcare: Key Strategic Developments, 2015-2017

Table: Lantheus Medical Imaging, Inc.: Key Strategic Developments, 2015-2017

Table: Bayer AG: Key Strategic Developments, 2015-2017

Table: Bracco Imaging S.P.A: Key Strategic Developments, 2015-2017

Table: Eczacibasi-Monrol Nuclear Products: Key Strategic Developments, 2015-2017

Table: Nordion, Inc.: Key Strategic Developments, 2015-2017

Table: Advanced Accelerator Applications S.A.: Key Strategic Developments, 2015-2017

Table: Iba Molecular: Key Strategic Developments, 2015-2017


List of Figures

Figure: Global Radiopharmaceuticals Market Share, By Type, 2014 & 2023

Figure: Global Radiopharmaceuticals Market, By Procedural Volumes, 2014 & 2023 ($Million)

Figure: Global Radiopharmaceuticals Market, By Application, 2014 & 2023 ($Million)

Figure: Global Radiopharmaceuticals Market, By Region, 2014 & 2023 ($Million)

Figure: Global Radiopharmaceuticals Sales and Sales Share by Type (2014-2017)

Figure: Global Radiopharmaceuticals Revenue and Revenue Share by Type (2014-2017)

Figure: Global Radiopharmaceuticals Sales and Sales Share by Procedural Volumes (2014-2017)

Figure: Global Radiopharmaceuticals Revenue and Revenue Share by Procedural Volumes (2014-2017)

Figure: Global Radiopharmaceuticals Sales and Sales Share by Application (2014-2017)

Figure: Global Radiopharmaceuticals Revenue and Revenue Share by Application (2014-2017)

Figure: North America Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Figure: Europe Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Figure: Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Figure: Rest of the World Radiopharmaceuticals Sales and Growth Rate (2014-2017)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*